Literature DB >> 17359914

RNA interference: a tool for querying nervous system function and an emerging therapy.

Beverly L Davidson1, Ryan L Boudreau.   

Abstract

RNA interference (RNAi), a mediator of gene silencing, has swiftly become one of the most exciting and applicable biological discoveries. There has been rapid progress in identifying RNAi pathway components and elucidating the mechanisms of microRNA (miRNA) biogenesis and gene suppression. As a result, RNAi technologies have been successfully employed in a variety of systems as biological tools, and studies are underway to test the therapeutic utility of RNAi. In the span of several years, significant advances in the delivery of inhibitory RNAs in the nervous system have been made. We have glimpses into how endogenous miRNAs interface with neuronal development and function; in addition, RNAi has shown therapeutic efficacy in several mouse models of human neurological conditions. In this review, we summarize the current state-of-the-art of RNAi and its utility to neuroscientists.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17359914     DOI: 10.1016/j.neuron.2007.02.020

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  23 in total

Review 1.  Huntington's disease: progress toward effective disease-modifying treatments and a cure.

Authors:  Carl D Johnson; Beverly L Davidson
Journal:  Hum Mol Genet       Date:  2010-04-26       Impact factor: 6.150

Review 2.  Therapeutic application of RNAi: is mRNA targeting finally ready for prime time?

Authors:  Dirk Grimm; Mark A Kay
Journal:  J Clin Invest       Date:  2007-12       Impact factor: 14.808

Review 3.  Lentiviral vector-mediated RNA silencing in the central nervous system.

Authors:  Thomas H Hutson; Edmund Foster; Lawrence D F Moon; Rafael J Yáñez-Muñoz
Journal:  Hum Gene Ther Methods       Date:  2013-11-01       Impact factor: 2.396

4.  Experimental approach to study of the gonadotropin-releasing hormone function by knockdown of its expression with RNA interference in ontogenesis.

Authors:  N N Dygalo; T S Kalinina; E L Chernolovskaya; M A Zenkova; G T Shishkina; M V Ugrumov
Journal:  Dokl Biol Sci       Date:  2009 May-Jun

5.  Gene delivery to the nervous system.

Authors:  Manfred Schubert; Xandra Breakefield; Howard Federoff; Robert M Frederickson; Pedro R Lowenstein
Journal:  Mol Ther       Date:  2008-04       Impact factor: 11.454

6.  Broad therapeutic benefit after RNAi expression vector delivery to deep cerebellar nuclei: implications for spinocerebellar ataxia type 1 therapy.

Authors:  Megan S Keiser; Ryan L Boudreau; Beverly L Davidson
Journal:  Mol Ther       Date:  2013-12-12       Impact factor: 11.454

Review 7.  Defining functional gene-circuit interfaces in the mouse nervous system.

Authors:  M E Soden; B B Gore; L S Zweifel
Journal:  Genes Brain Behav       Date:  2013-09-30       Impact factor: 3.449

Review 8.  RNAi: a potential new class of therapeutic for human genetic disease.

Authors:  Attila A Seyhan
Journal:  Hum Genet       Date:  2011-05-03       Impact factor: 4.132

Review 9.  MicroRNA implications across neurodevelopment and neuropathology.

Authors:  Sabata Martino; Ilaria di Girolamo; Antonio Orlacchio; Alessandro Datti; Aldo Orlacchio
Journal:  J Biomed Biotechnol       Date:  2009-10-13

10.  Co-expression of Argonaute2 Enhances Short Hairpin RNA-induced RNA Interference in Xenopus CNS Neurons In Vivo.

Authors:  Chih-Ming Chen; Shu-Ling Chiu; Wanhua Shen; Hollis T Cline
Journal:  Front Neurosci       Date:  2009-07-09       Impact factor: 4.677

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.